L-Citrulline BSA Conjugate

L-Citrulline BSA Conjugate is a specialized biochemical tool used to investigate protein citrullination, a post-translational modification where peptidyl-arginine is converted to peptidyl-citrulline. This process, catalyzed by peptidylarginine deiminases (PADs), alters protein structure and function, influencing cellular signaling and immune responses. In neuroscience, citrullination is increasingly recognized as a key player in neuroinflammation and neurodegeneration. Aberrant citrullination has been implicated in diseases such as Alzheimer’s, Parkinson’s, multiple sclerosis, and amyotrophic lateral sclerosis (ALS) . Citrullinated proteins accumulate in reactive astrocytes and myelin aggregates, contributing to axonal damage and motor neuron degeneration. The L-Citrulline BSA Conjugate serves as a molecular mimic to detect citrullinated epitopes via immunoassays, enabling precise mapping of citrullination patterns in brain tissue. This aids in identifying disease-specific biomarkers and understanding PAD dysregulation in the central nervous system. Emerging research suggests that targeting citrullination pathways may offer novel therapeutic strategies and improve diagnostic accuracy in neurodegenerative disorders. Thus, L-Citrulline BSA Conjugate is a valuable reagent in translational neuroscience, bridging molecular pathology with clinical innovation.

L-Citrulline BSA Conjugate, L-Citrulline-BSA, L-Citrulline (BSA), L-Citrulline Bovine serum albumin, L-Citrulline Bovine Serum Albumin Conjugate, L-Citrulline-BSA conjugate, L-Citrulline (BSA) conjugate, 2-Amino-5- (carbamoylamino) pentanoic acid, Citrulline BSA Conjugate, Citrulline-BSA, Citrulline (BSA), Citrulline Bovine serum albumin, Citrulline Bovine Serum Albumin Conjugate, Citrulline-BSA conjugate, Citrulline (BSA) conjugate, Citrulline-modified BSA